CSTL - CIK 0001447362
CASTLE BIOSCIENCES INC (CSTL) reported revenue of $344.23M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $344.23M | +3.7% |
| FY 2024 | $332.07M | +51.1% |
| FY 2023 | $219.79M | +60.4% |
| FY 2022 | $137.04M | +45.7% |
| FY 2021 | $94.08M | +50.2% |
| FY 2020 | $62.65M | +20.8% |
| FY 2019 | $51.87M | +127.6% |
| FY 2018 | $22.79M | - |
CASTLE BIOSCIENCES INC (CSTL) reported revenue of $344.23M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, CASTLE BIOSCIENCES INC's revenue grew from $22.79M to $344.23M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.